Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat

Ting Wang, Ru Yi, Linden Ann Green, Sarvesh Chelvanambi, Michael Seimetz, Matthias Clauss

Research output: Contribution to journalReview article

31 Scopus citations

Abstract

With effective antiretroviral therapy (ART), many HIV-infected people die of diseases other than acquired immune deficiency syndrome (AIDS). In particular, coronary artery disease has emerged as one of most critical complications of HIV infection and a major cause of morbidity and mortality. Although reportedly antiretroviral combination therapy itself may accelerate atherosclerosis by enhancing dyslipidemia, most recent epidemiological studies support the notion that HIV infection itself contributes to cardiovascular disease. However, it is still a mystery how the virus can contribute to cardiovascular disease development even while suppressed by ARTs. This review discusses the current understanding of interactions between HIV infection and cardiovascular diseases in both clinical and experimental studies with special focus on those viral proteins that are still produced by HIV. This will help infectious disease/vascular biology experts to gain insights into the pathophysiological mechanisms of HIV-associated cardiovascular disease and new trends to treat and prevent cardiovascular disease in the HIV-infected population.

Original languageEnglish (US)
Article number6850
Pages (from-to)279-282
Number of pages4
JournalCardiovascular Pathology
Volume24
Issue number5
DOIs
StatePublished - Sep 1 2015

    Fingerprint

Keywords

  • ART
  • Cardiovascular diseases
  • Endothelial dysfunction
  • HIV Nef
  • HIV Tat

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Cardiology and Cardiovascular Medicine

Cite this